Skip to content
10-K

Annual Report

Arno Therapeutics, Inc

0001144204-16-091477

← back to feed
Filed
Mar 30, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Mar 23, 2016 41.56M sh
Shares Diluted FY 2015 · Dec 31, 2015 20.41M sh
Shares Diluted FY 2015 · Dec 31, 2014 24.81M sh
Capex FY 2015 · Dec 31, 2015 $0
Capex FY 2015 · Dec 31, 2014 $20.1K
Long Term Debt FY 2015 · Dec 31, 2015 $2.09M
Long Term Debt FY 2015 · Dec 31, 2014 $0
Cash And Equivalents FY 2015 · Dec 31, 2015 $66.99K
Cash And Equivalents FY 2015 · Dec 31, 2014 $7.95M
Cash And Equivalents FY 2015 · Dec 31, 2013 $26.77M
Stockholders Equity FY 2015 · Dec 31, 2015 −$8.62M
Stockholders Equity FY 2015 · Dec 31, 2014 −$588.89K
Stockholders Equity FY 2015 · Dec 31, 2013 −$12.88M
Current Liabilities FY 2015 · Dec 31, 2015 $4.23M
Current Liabilities FY 2015 · Dec 31, 2014 $2.16M
Total Liabilities FY 2015 · Dec 31, 2015 $8.99M
Total Liabilities FY 2015 · Dec 31, 2014 $8.84M
Current Assets FY 2015 · Dec 31, 2015 $327.68K
Current Assets FY 2015 · Dec 31, 2014 $8.21M
Total Assets FY 2015 · Dec 31, 2015 $361.24K
Total Assets FY 2015 · Dec 31, 2014 $8.25M
Eps Diluted FY 2015 · Dec 31, 2015 −$0.56
Eps Diluted FY 2015 · Dec 31, 2014 $0.31
Eps Basic FY 2015 · Dec 31, 2015 −$0.56
Eps Basic FY 2015 · Dec 31, 2014 $0.38
Sga Expense FY 2015 · Dec 31, 2015 $4.76M
Sga Expense FY 2015 · Dec 31, 2014 $6.65M
Rd Expense FY 2015 · Dec 31, 2015 $8.65M
Rd Expense FY 2015 · Dec 31, 2014 $14.84M
Net Income FY 2015 · Dec 31, 2015 −$11.51M
Net Income FY 2015 · Dec 31, 2014 $7.77M
Operating Income FY 2015 · Dec 31, 2015 −$13.41M
Operating Income FY 2015 · Dec 31, 2014 −$21.49M